JFG
BPMC

Jefferies Financial Group’s Blueprint Medicines BPMC Stock Holding History

Jefferies Financial Group’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-8,500
Closed -$786K – 1607
2024
Q3 		$786K Hold
8,500
– – 0.01% 847
2024
Q2 		$916K Hold
8,500
– – 0.01% 779
2024
Q1 		$806K Sell
8,500
-2,800
-25% -$240K 0.01% 899
2023
Q4 		$1.04M Sell
11,300
-11,100
-50% -$719K 0.01% 931
2023
Q3 		$1.12M Hold
22,400
– – 0.01% 790
2023
Q2 		$1.42M Buy
22,400
+11,300
+102% +$614K 0.01% 784
2023
Q1 		$499K Hold
11,100
– – ﹤0.01% 1091
2022
Q4 		$486K Buy
+11,100
New +$532K ﹤0.01% 1068

Other funds holding BPMC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Jefferies Financial Group's BPMC Position: Q2 2025 in Review

Jefferies Financial Group sold out of Blueprint Medicines (BPMC) in Q2 2025, closing a stake of 45,200 shares — an estimated $4M sold.

Jefferies Financial Group first reported a position in BPMC in Q4 2022 and held it in 10 quarters. The position peaked at $4.58M in Q3 2024. 354 funds tracked by Wall St. Rank hold BPMC as of Q2 2025.

  • Jefferies Financial Group reported no remaining Blueprint Medicines position as of Q2 2025 after selling out during the quarter.
  • Jefferies Financial Group sold 45,200 Blueprint Medicines shares in Q2 2025, an estimated $4M.
  • Jefferies Financial Group first reported a position in Blueprint Medicines in Q4 2022 and held it in 10 quarters.
  • Jefferies Financial Group's Blueprint Medicines position peaked at $4.58M in Q3 2024.
  • 354 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2025.

Based on Jefferies Financial Group's 13F filing for Q2 2025, filed 12 Aug 2025.